Value through Innovation17 January 2013
Corporate Profile
  • Home
  • Search Result

Page content

jump to main navigation jump to meta navigation

Your search results.

  1. Asthma Media Backgrounder

    When a person with asthma comes into contact with an asthma trigger (e.g. viral infection, pollen, smoke), their airways can become more inflamed, swollen and constricted and produce excess mucus.1 These reactions cause the airways to become narrower and irritated, making it difficult to breathe1

    • Size: 290 kB
    • Last Update: 8.11.2012

  2. R&D conference view 2012

    • Size: 67 kB
    • Last Update: 9.11.2012

  3. COPD infographics

    2. World Health Organisation. Global surveillance, prevention and control of chronic respiratory diseases: A comprehensive approach. Available from: http://whqlibdoc.who.int/publications/ G l o b a l lyup to 210 million people live with C O P D c i g a r e t c i g a r e t t e s m o k e

    • Size: 2 MB
    • Last Update: 8.11.2012

  4. Boehringer Ingelheim: Respiratory Research & Development Timeline

    Launch of Combivent® for the treatment of COPD, containing ipratropium bromide and salbutamol is launched, a short-acting anti-cholinergic for the treatment of patients with chronic obstructive pulmonary disease (COPD)

    • Size: 7 MB
    • Last Update: 8.11.2012

  5. R&D conference 2012

    • Size: 17 kB
    • Last Update: 9.11.2012

  6. R&D Conference 2012

    • Size: 5 kB
    • Last Update: 8.11.2012

  7. An exclusive look at asthma

    Dr. Dr. Bernd Disse, Therapeutic Area Head Respiratory, Boehringer Ingelheim

    • Size: 2 MB
    • Last Update: 8.11.2012

  8. Prof. Barner

    • Size: 12 kB
    • Last Update: 9.11.2012

  9. Prof. Barner

    • Size: 15 kB
    • Last Update: 9.11.2012

  10. R&D conference 2012 broschures

    • Size: 40 kB
    • Last Update: 9.11.2012
back to top